$1.15
0.1717.35%
At close: -
$1.14
-0.01-0.87%
After Hours: 3:05 PM EDT
Context Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Context Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $-0.22 | $-0.09 | -144.4 % |
Jun 2024 | 2024-08-07 | $-0.04 | $-0.07 | 42.9 % |
Mar 2024 | 2024-05-08 | $-0.23 | $-0.38 | 39.5 % |
Dec 2023 | 2024-03-21 | $-0.42 | $-0.35 | -20.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Context Therapeutics (CNTX) is scheduled to report earnings on March 20, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
The Actual EPS was $-0.22, which missed the estimate of $-0.09.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.